Awareness and knowledge of autism among pharmacists

BackgroundIn the past few decades, the prevalence of autism has increased tremendously in the United States. The prevalence of autism is now higher than the combined prevalence of juvenile diabetes, pediatric cancer, and pediatric AIDS. As health care professionals with a high visibility in a community, pharmacists are likely to encounter more and more families having a child affected by this disorder.ObjectivesThe purpose of this study was to assess pharmacists’ awareness and knowledge of autism. The study aimed to assess pharmacists’ familiarity with autism symptoms, treatment medications, and community resources devoted to this disorder. Further, pharmacists’ knowledge of common myths associated with autism, etiology, prognosis, and treatment were assessed.MethodsUsing a cross-sectional design, an online survey of pharmacists registered in the state of Mississippi (MS) was conducted, using the Qualtrics software program. Descriptive analysis of study items was conducted.ResultsA total of 147 usable responses (5.8%) were received. The results indicated gaps in pharmacists’ awareness and knowledge of autism. Approximately, 23% of pharmacists did not know that autism is a developmental disorder, and 32% did not believe that genetics has a major role in autism etiology. More than 18% believed that vaccines can cause autism. Most (>90%) felt that they could benefit from autism continuing education (CE).ConclusionPolicy makers and autism agencies should consider providing educational interventions or CE programs to increase pharmacists’ awareness and knowledge of autism.